Tower Research Capital LLC (TRC) - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 97 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2023. The put-call ratio across all filers is 0.03 and the average weighting 1.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q2 2024$46,413
+350.2%
13,337
+725.3%
0.00%
Q1 2024$10,310
-83.7%
1,616
-83.5%
0.00%
-100.0%
Q4 2023$63,066
+53.0%
9,793
-44.7%
0.00%0.0%
Q3 2023$41,231
-31.7%
17,696
-30.3%
0.00%
-50.0%
Q2 2023$60,395
+109709.1%
25,376
-14.6%
0.00%0.0%
Q1 2023$55
+52.8%
29,728
+55.4%
0.00%
+100.0%
Q4 2022$36
-99.7%
19,125
+193.9%
0.00%
Q3 2022$14,000
+40.0%
6,507
+88.4%
0.00%
Q2 2022$10,000
-23.1%
3,454
+16.1%
0.00%
Q1 2022$13,000
-43.5%
2,974
-32.4%
0.00%
Q4 2021$23,000
-42.5%
4,400
-27.2%
0.00%
-100.0%
Q3 2021$40,000
+135.3%
6,048
+133.9%
0.00%
Q2 2021$17,0000.0%2,586
-16.0%
0.00%
Q1 2021$17,000
+21.4%
3,080
+91.1%
0.00%
Q4 2020$14,000
-77.0%
1,612
-69.0%
0.00%
-100.0%
Q3 2020$61,000
+335.7%
5,203
+484.6%
0.00%0.0%
Q2 2020$14,000
+250.0%
890
+41.0%
0.00%
Q1 2020$4,000
-86.2%
631
-71.7%
0.00%
-100.0%
Q4 2019$29,000
-69.8%
2,227
-26.8%
0.00%
-66.7%
Q1 2019$96,000
+4700.0%
3,041
+4372.1%
0.01%
Q3 2018$2,000680.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 7,346,829$15,723,00027.32%
TFG Asset Management GP Ltd 3,039,381$6,504,0000.78%
Nantahala Capital Management 5,215,788$11,162,0000.72%
Frazier Life Sciences Management, L.P. 3,746,857$8,018,0000.62%
HARBOR CAPITAL ADVISORS, INC. 148,454$318,0000.29%
DAFNA Capital Management LLC 496,150$1,062,0000.29%
Blackstone Inc. 17,985,611$38,4890.14%
Ikarian Capital, LLC 260,087$556,0000.11%
MYDA Advisors LLC 100,000$214,0000.10%
Privium Fund Management B.V. 113,528$253,0000.09%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders